Rayes, A., Pulsipher, M., Ebens, C., Oved, J., Mousallem, T., Mahadeo, K., … Malech, H. (2026). First in vivo hematopoietic stem cell (HSC) gene addition clinical trial: Initial results from EN-374-101 in X-linked chronic granulomatous disease (X-CGD). In MOLECULAR THERAPY (Vol. 34, pp. 833–834).

Rayes, Ahmad, Michael Pulsipher, Christen Ebens, Joseph Oved, Talal Mousallem, Kris Mahadeo, Donald Kohn, et al. “First in vivo hematopoietic stem cell (HSC) gene addition clinical trial: Initial results from EN-374-101 in X-linked chronic granulomatous disease (X-CGD).” In MOLECULAR THERAPY, 34:833–34, 2026.

Rayes A, Pulsipher M, Ebens C, Oved J, Mousallem T, Mahadeo K, et al. First in vivo hematopoietic stem cell (HSC) gene addition clinical trial: Initial results from EN-374-101 in X-linked chronic granulomatous disease (X-CGD). In: MOLECULAR THERAPY. 2026. p. 833–4.

Rayes, Ahmad, et al. “First in vivo hematopoietic stem cell (HSC) gene addition clinical trial: Initial results from EN-374-101 in X-linked chronic granulomatous disease (X-CGD).” MOLECULAR THERAPY, vol. 34, no. 5, 2026, pp. 833–34.

Rayes A, Pulsipher M, Ebens C, Oved J, Mousallem T, Mahadeo K, Kohn D, Prockop S, Dorsey M, Leiding J, Morris EC, Shamir E, Au P, Plescia C, Kiem H-P, Dietz AC, Booth C, Malech H. First in vivo hematopoietic stem cell (HSC) gene addition clinical trial: Initial results from EN-374-101 in X-linked chronic granulomatous disease (X-CGD). MOLECULAR THERAPY. 2026. p. 833–834.